The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections
about
Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markersUncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme.A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsFactors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAARTHIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in womenPrevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected personsThe effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infectionNonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.The association of HIV viral load with indirect markers of liver injury.HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosisAssociation between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional studyElevated alanine aminotransferase in antiretroviral-naïve HIV-infected African patients: magnitude and risk factors.HIV and liver disease forum: conference proceedingsRisk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infectionLiver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.A cross-sectional study of liver function tests in HIV-infected persons in Western India.Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients.Higher Levels of CYSTATIN C in HIV/AIDS Patients with Metabolic Syndrome.Analysis of HIV quasispecies suggests compartmentalization in the liver.HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD.Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.Low prevalence of chronic hypertransaminasemia in a cohort of HIV-infected patients with no coinfections.Editorial Commentary: Elevated Aminotransferase Levels Among HIV-Infected Persons: What's Lurking Under the Surface?Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
P2860
Q30387567-39E2A03D-4E91-4987-B5EF-099FC3428A3BQ31050092-8D7A575E-EB96-4410-AACD-3014CDB9580AQ33621724-8F9800C7-A28F-4BED-8EF8-7E98227C3D09Q33947453-DA414777-DCF5-4B94-A306-EADAEEB1C564Q33999798-365FA3D1-D338-47F7-AAC0-3CDCC6CD441CQ34070485-33DCB5C7-0258-4E84-BD4A-01B0FD250616Q35019825-5FA719D6-BE52-40C1-9CEA-61CF654EDACAQ35062602-720E3EC1-6441-4131-AD38-717B63C8283FQ35454587-0B44B8DB-1620-4B94-A19E-8BF748372C79Q35588143-82F3D1CD-5A9A-4110-B6FC-D0A9AC1353A7Q35681714-4D479AFA-3D1B-43A0-BCB0-32259AFE53B0Q35766031-1953489F-E451-40BC-8E47-B23828370FBBQ35803583-78BF7018-46EC-46D6-B867-F4F6B1A50EF1Q36080888-92F22816-AA63-4EA5-B07E-CF78B9B82EC2Q36835630-2F46F011-29CA-43BB-A47A-0635416CD0DEQ37056681-4A80016A-3630-47CB-8465-3B527E15D03EQ40271245-9D03CF4D-74C0-489E-977B-BD2BE0963881Q40357994-B7B3D83F-D176-4717-A076-70FEA956FF8FQ40750320-45C3A8E9-8DAE-4088-A5EE-5038CF406500Q41822943-03883519-495E-4FC5-B249-FD1ACC31DC49Q41919708-08A73EF3-2596-4C3B-9D2E-136388EBBD47Q41986511-4A3DC5D0-A0E3-4501-9A42-0591CE3FA7C8Q42266226-EDF42F2A-2E04-4018-A5FA-E978F4524B98Q42657454-B4EDDA1C-CAE5-43B2-9B84-D6A26AEC9F54Q44174121-5D3CD2E5-B116-4633-B667-854285BF9161Q44912567-3211B4AB-8687-48B9-A46F-317FA350E032Q46094964-5CC1CD8E-3FCA-4EC3-AC20-342D10536E4BQ46557460-8C8C5F4D-FB43-4C46-84E4-B81532EF9E55
P2860
The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prevalence and risk factor ...... hepatitis B or C coinfections
@en
The prevalence and risk factor ...... hepatitis B or C coinfections.
@nl
type
label
The prevalence and risk factor ...... hepatitis B or C coinfections
@en
The prevalence and risk factor ...... hepatitis B or C coinfections.
@nl
prefLabel
The prevalence and risk factor ...... hepatitis B or C coinfections
@en
The prevalence and risk factor ...... hepatitis B or C coinfections.
@nl
P2093
P2860
P1476
The prevalence and risk factor ...... hepatitis B or C coinfections
@en
P2093
Daniel Nixon
Kenny Snider
Richard K Sterling
Steven Chiu
P2860
P2888
P304
P356
10.1007/S10620-007-9999-6
P577
2007-10-16T00:00:00Z